Michael Oellerich

Michael Oellerich's AcademicInfluence.com Rankings

Michael Oellerich

Chemistry

#4414

World Rank

#5495

Historical Rank

Organic Chemistry

#728

World Rank

#825

Historical Rank

chemistry Degrees

Michael Oellerich

Philosophy

#8883

World Rank

#12346

Historical Rank

Logic

#5894

World Rank

#7342

Historical Rank

philosophy Degrees

Download Badge

Chemistry
Philosophy

Michael Oellerich's Degrees

Doctorate Medicine University of Göttingen
PhD Clinical Chemistry University of Göttingen

Why Is Michael Oellerich Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael Oellerich's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference (2009) (442)
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation (2006) (313)
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. (2002) (279)
Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial (2008) (260)
Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion (2001) (258)
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient (1993) (252)
Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications (2003) (248)
Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus Panel (1995) (236)
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. (1998) (217)
Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. (2013) (212)
Identification of glucoside and carboxyl‐linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil (1999) (207)
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. (2005) (201)
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. (2000) (191)
Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. (2002) (190)
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea (2003) (178)
LIGNOCAINE METABOLITE FORMATION AS A MEASURE OF PRE-TRANSPLANT LIVER FUNCTION (1989) (166)
Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk (2013) (155)
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes (2001) (153)
Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. (2000) (151)
Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? (2000) (150)
Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. (1999) (146)
Twelve‐Month Evaluation of the Clinical Pharmacokinetics of Total and Free Mycophenolic Acid and Its Glucuronide Metabolites in Renal Allograft Recipients on Low Dose Tacrolimus in Combination with Mycophenolate Mofetil (2003) (146)
Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Function (1987) (146)
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. (2001) (139)
Therapeutic monitoring of mycophenolic acid. A consensus panel report. (1998) (132)
Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study (2017) (130)
THERAPEUTIC DRUG MONITORING OF CYCLOSPORINE AND TACROLIMUS (1998) (129)
Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. (1998) (127)
Predictors of one‐year pretransplant survival in patients with cirrhosis (1991) (123)
Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. (2006) (121)
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. (1999) (118)
Assessment of pretransplant prognosis in patients with cirrhosis. (1991) (117)
Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. (2002) (117)
Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. (1998) (113)
Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. (1999) (110)
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods. (2003) (109)
Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. (2007) (109)
Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. (2006) (107)
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. (2007) (105)
Therapeutic Drug Monitoring of Everolimus: A Consensus Report (2016) (104)
Using circulating cell-free DNA to monitor personalized cancer therapy (2017) (102)
Pharmacokinetics and Protein Adduct Formation of the Pharmacologically Active Acyl Glucuronide Metabolite of Mycophenolic Acid in Pediatric Renal Transplant Recipients (2002) (98)
Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler. (1999) (97)
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. (2005) (97)
Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. (2004) (94)
Absolute quantification of donor‐derived cell‐free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study (2019) (91)
The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes. (2001) (91)
The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments. (2006) (89)
Enzyme Immunoassays in Clinical Chemistry: Present Status and Trends (1980) (88)
Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability (2005) (86)
Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. (2007) (83)
Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. (2008) (83)
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation (2016) (80)
Two-Hour Cyclosporine Concentration Determination: An Appropriate Tool to Monitor Neoral Therapy? (2002) (78)
AmpliChip CYP450 GeneChip®: A New Gene Chip That Allows Rapid and Accurate CYP2D6 Genotyping (2006) (78)
Effect of Cyclosporine Withdrawal on Mycophenolic Acid Pharmacokinetics in Kidney Transplant Recipients With Deteriorating Renal Function: Preliminary Report (2001) (78)
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee (2016) (77)
Differential S-nitrosylation of proteins in Alzheimer’s disease (2014) (77)
Plasma Concentrations of Mycophenolic Acid Acyl Glucuronide Are Not Associated with Diarrhea in Renal Transplant Recipients (2007) (77)
Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach (2013) (76)
A NOVEL MANAGEMENT STRATEGY OF STEROID-FREE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION: EFFICACY AND SAFETY OF TACROLIMUS AND MYCOPHENOLATE MOFETIL (2001) (74)
Significance of arterial ketone body ratio measurement in human liver transplantation. (1990) (74)
Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. (2006) (73)
Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. (1999) (73)
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients (2006) (73)
The MEGX Test: A Tool for the Real-Time Assessment of Hepatic Function (2001) (72)
Prenatal Programming of Metabolic Syndrome in the Common Marmoset Is Associated With Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 (2009) (72)
Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. (1990) (70)
Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite. (1999) (68)
Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. (1997) (67)
Enzyme-immunoassay: a review. (1984) (66)
Biomarkers as a Tool for Management of Immunosuppression in Transplant Patients (2010) (63)
The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. (2004) (63)
Everolimus Exposure in Cardiac Transplant Recipients is Influenced by Concomitant Calcineurin Inhibitor (2008) (56)
New approaches to cyclosporine monitoring raise further concerns about analytical techniques. (2000) (56)
Analytic aspects of monitoring therapy with thiopurine medications. (2004) (55)
Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). (2005) (55)
Plasma lipids are not oxidized during hemodialysis. (1994) (54)
Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. (1985) (54)
Validation of an Abbreviated Pharmacokinetic Profile for the Estimation of Mycophenolic Acid Exposure in Pediatric Renal Transplant Recipients* (2006) (54)
Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells. (2011) (54)
Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. (2004) (53)
Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine? (1996) (53)
Evaluation of quantitative liver function tests in liver donors. (1987) (52)
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. (2021) (52)
Leveraging the real value of laboratory medicine with the value proposition. (2016) (51)
Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring? (2012) (51)
Monitoring Cyclosporin in Blood: Between-Assay Differences at Trough and 2 Hours Post-dose (C2) (2003) (50)
Pharmacokinetics of Theophylline (1984) (50)
Phenotypic and Genotypic Analysis of Thiopurine S‐Methyltransferase Polymorphism in the Bulgarian Population (2003) (49)
Immuno-reactive molecules identified from the secreted proteome of Aspergillus fumigatus. (2010) (49)
Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. (2004) (48)
Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. (2007) (47)
Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue (2004) (47)
Pharmacokinetics and safety of lidocaine and monoethylglycinexylidide in liposuction: a microdialysis study. (2004) (45)
AcylMPAG Plasma Concentrations and Mycophenolic Acid-Related Side Effects in Patients Undergoing Renal Transplantation Are Not Related to the UGT2B7-840G>A Gene Polymorphism (2008) (45)
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients (2022) (44)
Azathioprine Pharmacogenetics: The Relationship between 6-Thioguanine Nucleotides and Thiopurine Methyltransferase in Patients after Heart and Kidney Transplantation (1996) (44)
Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy. (1988) (44)
Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass (2004) (43)
Use of Graft-Derived Cell-Free DNA as an Organ Integrity Biomarker to Reexamine Effective Tacrolimus Trough Concentrations After Liver Transplantation (2014) (43)
A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis. (2002) (43)
Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease (1994) (42)
No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients (2008) (42)
Analysis of ITPA Phenotype-Genotype Correlation in the Bulgarian Population Revealed a Novel Gene Variant in Exon 6 (2007) (42)
Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections (2013) (42)
Lidocaine Metabolite Formation as a Measure of Liver Function in Patients with Cirrhosis (1990) (42)
An Open Prospective Pilot Study on the Use of Rapamycin after Penetrating High-Risk Keratoplasty (2006) (42)
C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in bulgaria (1999) (41)
Pharmacokinetics of Mycophenolate Mofetil in Hematopoietic Stem Cell Transplant Recipients (2007) (41)
Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation. (1995) (40)
Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. (1998) (40)
Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer’s disease patients (2012) (39)
Novel cytosolic allergens of Aspergillus fumigatus identified from germinating conidia. (2010) (39)
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury (2021) (39)
PHARMACOKINETICS AND BIOAVAILABILITY OF MYCOPHENOLIC ACID AFTER INTRAVENOUS ADMINISTRATION AND ORAL ADMINISTRATION OF MYCOPHENOLATE MOFETIL TO HEART TRANSPLANT RECIPIENTS (2004) (38)
Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics. (2006) (36)
Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions. (2014) (36)
Influence of Gender on the Monoethylglycinexylidide Test in Normal Subjects and Liver Donors (1994) (36)
The EMIT® FreeLevel™ Ultrafiltration Technique Compared with Equilibrium Dialysis and Ultracentrifugation to Determine Protein Binding of Phenytoin (1984) (35)
Functional state of the donor liver and early outcome of transplantation. (1991) (35)
Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver. (2014) (35)
Analysis of the cellular Aspergillus fumigatus proteome that reacts with sera from rabbits developing an acquired immunity after experimental aspergillosis (2010) (35)
Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL tests. (1990) (34)
Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney. (2007) (34)
Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. (2006) (33)
Characterization of the Inosine Triphosphatase (ITPA) Gene: Haplotype Structure, Haplotype-Phenotype Correlation and Promoter Function (2008) (33)
N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report (2004) (33)
Total oxygen consumption, ketone body ratio and a special score as early indicators of irreversible liver allograft dysfunction. (1989) (33)
Cyclosporin A Absorption Profiles in Pediatric Renal Transplant Recipients Predict the Risk of Acute Rejection (2004) (32)
Rapid detection of ITPA 94C>A and IVS2 + 21A>C gene mutations by real-time fluorescence PCR and in vitro demonstration of effect of ITPA IVS2 + 21A>C polymorphism on splicing efficiency. (2004) (32)
Long-Term Pharmacokinetics of Mycophenolic Acid in Pediatric Renal Transplant Recipients Over 3 Years Posttransplant (2008) (31)
Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite. (2000) (31)
Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II). (1998) (31)
Differential Expression of Proteins in Brain Regions of Alzheimer’s Disease Patients (2013) (30)
SYNERGISTIC EFFECTS OF SIROLIMUS WITH CYCLOSPORINE AND TACROLIMUS: ANALYSIS OF IMMUNOSUPPRESSION ON LYMPHOCYTE PROLIFERATION AND ACTIVATION IN RAT WHOLE BLOOD (2004) (29)
T-786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis. (2009) (29)
Determination of Thiopurine Methyltransferase Phenotype in Isolated Human Erythrocytes Using a New Simple Nonradioactive HPLC Method (2003) (29)
Comparability and Imprecision of 8 Frequently Used Commercially Available Immunoassays for Therapeutic Drug Monitoring (2014) (28)
Evaluation of the liver graft before procurement (1990) (28)
Multicenter Evaluation of a New Inosine Monophosphate Dehydrogenase Inhibition Assay for Quantification of Total Mycophenolic Acid in Plasma (2008) (27)
IDEBENONE PROTECTS HEPATIC MICROSOMES AGAINST OXYGEN RADICAL‐MEDIATED DAMAGE IN ORGAN PRESERVATION SOLUTIONS (1995) (27)
Changes in energy substrates in relation to arterial ketone body ratio after human orthotopic liver transplantation. (1993) (25)
Can the Roche hemolysis index be used for automated determination of cell-free hemoglobin? A comparison to photometric assays. (2013) (25)
Determination of thiopurine methyltransferase activity in isolated human erythrocytes does not reflect putative in vivo enzyme inhibition by sulfasalazine. (2004) (24)
Use of Total and Unbound Imatinib and Metabolite LC-MS/MS Assay to Understand Individual Responses in CML and GIST Patients (2011) (24)
Monoethylglycinexylidide as an Early Predictor of Posttraumatic Multiple Organ Failure (1995) (24)
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients. (2004) (24)
Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients (2004) (24)
Carnitine: metabolism, function and clinical application. (1990) (24)
Mycophenolic Acid Interaction With Cyclosporine and Tacrolimus In Vitro and In Vivo: Evaluation of Additive Effects on Rat Blood Lymphocyte Function (2005) (23)
Oxidative Modification of Low Density Lipoproteins by Human Polymorphonuclear Leukocytes (1993) (23)
Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment (2011) (23)
Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation. (2020) (22)
The use of lidocaine as a test of liver function in liver transplantation. (1996) (22)
Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil. (2001) (22)
Caspase-activation and induction of inducible nitric oxide-synthase during TNF alpha-triggered apoptosis. (1999) (22)
MODULAR ANALYTICS: A New Approach to Automation in the Clinical Laboratory (2005) (22)
Increased serum levels of hyaluronic acid in pregnancies complicated by preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome. (1998) (22)
Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection. (2008) (21)
Mycophenolic Acid Displays IMPDH-Dependent and IMPDH-Independent Effects on Renal Fibroblast Proliferation and Function (2010) (21)
Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer. (2018) (21)
Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation. (2017) (21)
Pitfalls in monitoring tacrolimus (FK 506). (1997) (21)
Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition. (2019) (20)
Allergic aspergillosis and the antigens of Aspergillus fumigatus. (2014) (20)
Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass. (1996) (20)
Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury (2015) (20)
Stability of mycophenolic acid and mycophenolic acid glucuronide in human plasma. (1999) (20)
Monitoring of mycophenolic acid in pediatric renal transplant recipients. (2001) (19)
cDNA Microarray Analysis Reveals New Candidate Genes Possibly Linked to Side Effects Under Mycophenolate Mofetil Therapy (2004) (19)
Pre-analytical effects of different lithium heparin plasma separation tubes in the routine clinical chemistry laboratory (2011) (19)
Cyclosporin A trough levels correlate with serum lipoproteins and apolipoproteins: implications for therapeutic drug monitoring of cyclosporin A. (1997) (19)
Arterial blood ketone body ratio as an indicator for viability of donor livers. (1991) (18)
Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A, *3B, and *3C. (2004) (18)
NAT2*5/*5 Genotype (341T>C) Is a Potential Risk Factor for Schistosomiasis-Associated Bladder Cancer in Egyptians (2005) (18)
Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome (2011) (18)
Intracellular ATP Production in CD4+ T Cells as a Predictor for Infection and Allograft Rejection in Trough-Level Guided Pediatric Liver Transplant Recipients Under Calcineurin-Inhibitor Therapy (2012) (18)
Ketone body ratio as an indicator of early graft survival in clinical liver transplantation (1991) (18)
A simple and reliable reverse-phase high-performance liquid chromatographic procedure for determination of paclitaxel (taxol) in human serum. (1997) (18)
How Delayed Graft Function Impacts Exposure to Mycophenolic Acid in Patients After Renal Transplantation (2011) (18)
Clinical Utility of a New Enzymatic Assay for Determination of Mycophenolic Acid in Comparison With an Optimized LC-MS/MS Method (2009) (17)
Prenatal Dexamethasone Exposure Does Not Alter Blood Pressure and Nephron Number in the Young Adult Marmoset Monkey (2009) (17)
Use of Aminoglycosides in Critically Ill Patients: Individualization of Dosage Using Bayesian Statistics and Pharmacokinetic Principles (1988) (17)
Suppression of leukocyte-enhanced cold ischemia/reperfusion injury of liver endothelium with the benzoquinone antioxidant idebenone. (1997) (17)
Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score. (1993) (17)
Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates. (1996) (17)
Confronting the challenge: individualized immune monitoring after organ transplantation using the cellular immune function assay. (2012) (17)
Differential Proteomic Analysis of Lymphocytes Treated With Mycophenolic Acid Reveals Caspase 3-Induced Cleavage of Rho GDP Dissociation Inhibitor 2 (2009) (16)
CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess. (2010) (16)
Circulating cell-free DNA- diagnostic and prognostic applications in personalized cancer therapy. (2019) (15)
The influence of hydrazine, phenelzine and nialamide on gluconeogenesis and cell respiration in the perfused guinea‐pig liver (1977) (15)
Determination of Lipid Hydroperoxides in Serum Iodometry and High Performance Liquid Chromatography Compared (1992) (14)
High-dose methotrexate: pharmacokinetics in children and young adults. (1988) (14)
The Monoethylglycinexylidide (MEGX) Test as a Marker of Hepatic Dysfunction in Septic Patients with Pneumonia (2000) (14)
Hydrazonopropionic acid, a new class of hypoglycemic substances. 2. Influence of 2-(phenylethylhydrazono)- and 2-(2-cyclohexyl-ethylhydrazono)-propionic acid on redox systems, acid base status and monoamino oxidase activity. (1980) (14)
c-fos and c-jun mRNA expression in a pig liver model of ischemia/reperfusion: effect of extended cold storage and the antioxidant idebenone. (2000) (14)
Differential proteome and phosphoproteome signatures in human T‐lymphoblast cells induced by sirolimus (2010) (14)
Pharmacokinetics of Mycophenolic Acid and Its Glucuronide Metabolites in Stable Adult Liver Transplant Recipients With Renal Dysfunction on a Low-Dose Calcineurin Inhibitor Regimen and Mycophenolate Mofetil (2009) (14)
Therapeutic drug monitoring of tacrolimus early after liver transplantation. (2002) (13)
Monitoring of TPMT in heart transplant recipients under immunosuppressive therapy with azathioprine. (1995) (13)
Multicenter evaluation of a new automated electrochemiluminescence immunoassay for the quantification of testosterone compared to liquid chromatography tandem mass spectrometry. (2011) (13)
How to handle mycophenolate mofetil in combination with tacrolimus? (1998) (12)
Potential Biomarkers in the Sera of Breast Cancer Patients from Bahawalpur, Pakistan (2012) (12)
Evaluation of an immunoassay for mycophenolic acid. (2000) (12)
Relationship of apolipoproteins Al, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post‐transplant period (1995) (12)
Individualization of 5-fluorocytosine therapy. (1994) (12)
Hydrazonopropionic acids, a class of hypoglycemic substances. 1. Hypoglycemic effect of 2-(phenylethylhydrazono)- and 2-(2-cyclohexyl-ethylhydrazono)-propionic acid. (1979) (12)
Performance evaluation of the new ADVIA Centaur system cyclosporine assay (single-step extraction). (2010) (12)
Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition. (2020) (12)
Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors. (1989) (12)
A value proposition for natriuretic peptide measurement in the assessment of patients with suspected acute heart failure. (2019) (12)
Differential Kidney Proteome Profiling in a Murine Model of Renal Fibrosis under Treatment with Mycophenolate Mofetil (2011) (12)
Acceleration of hepatocellular energy by idebenone during early reperfusion after cold preservation ameliorates heat shock protein 70 gene expression in a pig liver model. (1997) (12)
Therapeutic drug monitoring - Key to personalized pharmacotherapy. (2017) (12)
CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. (2013) (12)
Determination of Methotrexate in Serum by a Rapid, Fully Mechanized Enzyme Immunoassay (EMIT) (1980) (12)
Treatment of nocturnal asthma: the role of sustained-release theophylline and oral beta-2-mimetics. (1987) (11)
Hydrazonopropionic acids, a new class of hypoglycemic substances, 3. Inhibition of jejunal glucose uptake in the rat and guinea pig. (1984) (11)
Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series (2021) (11)
Mycophenolate Sodium Does Not Reduce the Incidence of GI Adverse Events Compared with Mycophenolate Mofetil (2005) (11)
Effect of the Antioxidant Idebenone on Adverse Events Under Mycophenolate Mofetil Therapy in a Rat Model (2008) (11)
The value of serial determination of MEGX and hyaluronic acid early after orthotopic liver transplantation (1996) (11)
Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial (2017) (11)
Plasminogen activities and concentrations in patients with sporadic Creutzfeldt–Jakob disease (2004) (11)
Genotyping of CYP3A5 Polymorphisms among Bulgarian Patients with Sporadic Colorectal Cancer and Controls (2007) (11)
Qualitative assessment of liver function after hypovolemic, hypoxemic, and ischemic shock in a transplantation model. (1988) (10)
Determination of MEGX by HPLC with fluorescence detection. (1997) (10)
Mycophenolic Acid Predose Concentrations and Renal Function in a Mouse Model for Progressive Renal Fibrosis (2010) (10)
Drug Screening by Enzyme Immunoassay (EMIT) and Thin-Layer Chromatography (Drug Skreen (1977) (10)
Superiority of Combined CK-MB and Troponin I Measurements for the Early Risk Stratification of Unselected Patients Presenting with Acute Chest Pain (1999) (10)
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? - Considerations on pre-analytical aspects by the IFCC workgroup cfDNA. (2021) (10)
Postoperative recovery of mitochondrial function of the human liver graft procured and preserved with University of Wisconsin (UW) solution (1990) (10)
Hydrazonopropionic acids, a new class of hypoglycemic substances. 5. Inhibition of hepatic gluconeogenesis by 2-(3-methylcinnamyl-hydrazono)-propionate in the rat and guinea pig. (1985) (10)
A Universal Droplet Digital PCR Approach for Monitoring of Graft Health After Transplantation Using a Preselected SNP Set. (2018) (9)
Circulating Cell-Free DNA-Diagnostic and Prognostic Applications in Personalized Cancer Therapy. (2019) (9)
No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells (2002) (9)
Evaluation of hepatic excretory system function by determination of serum bile acid clearance early after liver transplantation. (1992) (9)
Determination of monoethylglycinexylidide by fluorescence polarization immunoassay in highly icteric serum samples: modified precipitation procedure and HPLC compared. (1998) (9)
FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue. (2014) (9)
Thiopurines Induce Oxidative Stress in T-Lymphocytes: A Proteomic Approach (2015) (9)
Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients (2005) (8)
Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC--a multicenter evaluation. (1997) (8)
The changing face of laboratory medicine: a more service and less academically oriented profession? (2015) (8)
Biomarkers in transplantation medicine: guide to the next level in immunosuppressive therapy. (2012) (8)
Receiver operating characteristic (ROC) analysis of the ability of arterial ketone body ratio to predict graft outcome after liver transplantation — its sensitivity and specificity (1992) (8)
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies. (1998) (8)
Development of a porcine small bowel ex vivo perfusion model. (1998) (8)
Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma. (2007) (8)
Comparison of 8 Different Colorimetric, Radiochemical and Immunological Procedures for the Determination of Iron Binding Capacity (1973) (7)
Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function. (2002) (7)
Convenient syntheses of the in vivo carbohydrate metabolites of mycophenolic acid: reactivity of the acyl glucuronide (2009) (7)
Determination of Phenobarbital and Phenytoin in Serum by a Mechanized Enzyme Immunoassay (EMIT) in Comparison with a Gas-Liquid Chromatographie Method (1977) (7)
Evaluation of EMIT Adapted to the (Cobas) Bio Centrifugal Analyzer (1982) (7)
Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors (2021) (7)
[HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients]. (2003) (6)
Evaluation of the liver graft before procurement: Significance of arterial ketone body ratio in brain‐dead patients (1990) (6)
Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3‐hydroxy MEGX in humans (1998) (6)
Identification of the Novel Interacting Partners of the Mammalian Target of Rapamycin Complex 1 in Human CCRF-CEM and HEK293 Cells (2014) (6)
Drug monitoring and pharmacokinetics (1990) (6)
Crosstalk between Edc4 and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in mRNA Decapping (2014) (6)
A Novel Management Strategy of Steroid-Free Immunosuppression after Liver Trans- plantation: Efficacy and Safety of Tacrolimus and Mycophenolate Mofetil. Transplan- tation 2001; 71: 508. (2001) (6)
Hydrazonopropionic acids, a new class of hypoglycemic substances. 4. Hypoglycemic effect of 2-(3-methyl-cinnamylhydrazono)-propionate in the rat and guinea pig. (1984) (6)
Assessment Of Amplichip CYP450 Based CYP2D6-Genotyping And Phenotype Prediction Compared To PCR-RFLP-genotyping And Phenotyping By Metoprolol Pharmacokinetics: 43 (2005) (6)
Personalized immunosuppression in transplantation : role of biomarker monitoring and therapeutic drug monitoring (2016) (6)
Regulation of IL2 and NUCB1 in Mononuclear Cells Treated With Acyl Glucuronide of Mycophenolic Acid Reveals Effects Independent of Inosine Monophosphate Dehydrogenase Inhibition (2009) (6)
Mycophenolic acid reverses TGF beta‐induced cell motility, collagen matrix contraction and cell morphology in vitro (2015) (6)
Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor–Free Renal Transplant Recipients (2016) (6)
Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs. (2011) (6)
Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice (2014) (6)
Establishment of Thiopurine S-Methyltransferase Gene Knockdown in Jurkat T-lymphocytes: An In Vitro Model of TPMT Polymorphism (2012) (6)
Lack of correlation between Treg quantification assays in inflammatory bowel disease patients. (2015) (5)
Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases. (2000) (5)
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of monoethylglycinexylidide. (2001) (5)
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation (2022) (5)
Investigation of the Performance of the ES 600 Enzymun-Test® System. A Multicentre Study (1988) (5)
Monitoring of Cyclosporin and Azathioprine in Organ Transplantation (1997) (5)
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. (1995) (5)
Pre- and post-transplant assessment of liver function in paediatric liver transplantation (2005) (5)
[Diagnostic value of clinico-chemical studies. Criteria and their practical use]. (1978) (4)
Drugs and pesticides (1986) (4)
[Determination of digoxin in serum using enzyme immunotest]. (1978) (4)
The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients. (1994) (4)
Activity of free radical scavenging enzymes in red cells and plasma of patients undergoing extracorporeal low-density lipoprotein apheresis. (1998) (4)
Determination of Total and Free Phenytoin in Serum by Non-Isotopic Immunoassays and Gas Chromatography (1984) (4)
Assessment of short-term prognosis in liver transplant candidates with postnecrotic or biliary cirrhosis. (1991) (4)
Enprofylline: Pharmacokinetics and comparison with theophylline of acute effects on bronchial reactivity in normal subjects (2004) (4)
Receiver operating characteristic (ROC) analysis of the ability of arterial ketone body ratio to predict graft outcome after liver transplantation ‐ its sensitivity and specificity (1992) (4)
Comparison of the Seradyn Innofluor?? Certican?? Assay on TDXFLX?? System With LC/MS-MS: 27 (2005) (4)
Highly specific HPLC method for the determination of theophylline in serum (1984) (4)
Donor-derived cell-free DNA as a diagnostic tool in transplantation (2022) (4)
76 MYCOPHENOLIC ACID DETERMINATION AFTER SOLID ORGAN TRANSPLANTATION: RP-HPLC AND EMIT™ COMPARED (1997) (4)
Hydrazonopropionic acids, a new class of non-hormonal hypoglycaemic compounds. (1979) (4)
Molecular Approaches to Transplant Monitoring; Is the Horizon Here? (2021) (3)
Inhibition of mitochondrial carnitine acylcarnitine translocase by hypoglycaemia-inducing substances. (1990) (3)
Marmoset glutathione peroxidases: cDNA sequences, molecular evolution, and gene expression (2006) (3)
Evaluation of Enzyme Immunoassays for Determination of Thyroxine (EMIT, ENZYMUN) and of Thyroxine Binding Index (1979) (3)
Monitoring of Therapeutic Serum Concentrations of Antiepileptic Drugs by a Newly Developed Gas Chromatographic Procedure and Enzyme Immunoassay (EMIT): A Comparative Study (1981) (3)
CYP2D6 and tamoxifen: pharmacogenetic reinvention of an established drug? 1 (2009) (3)
Monitoring of Serum Theophylline Concentrations by a Fully Mechanized Enzyme Immunoassay (EMIT) (1979) (3)
Determination of Theophylline in Saliva, Using Fluorescence Polarization Immunoassay (FPIA) (1985) (3)
Assessment of short-term prognosis in transplant candidates with cirrhosis (1989) (3)
73 AN HPLC PROCEDURE FOR SIMULTANEOUS DETERMINATION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE IN HUMAN PLASMA (1997) (3)
Individually tailored immunosuppression: is there a role for biomarkers? (2011) (3)
Cell free DNA as a marker of transplant graft injury (liquid biopsy). (2015) (3)
Methotrexate: Specific HPLC routine method involving column switching (1988) (3)
Inhibition of gluconeogenesis and of cell respiration by 1-(2-pyrimidinyl)-4-imino-1,4-dihydropyridinium chloride in perfused guinea pig liver. (1975) (3)
Pharmacokinetics of 6-Thioguanine nucleotides under i.v. Therapy with Azathioprine. (1999) (3)
Prodrug metabolites: implications for therapeutic drug monitoring. (2001) (3)
Offie Soldin, PhD, MBA. (2015) (3)
Time-Stratified correlation analysis of Emit and HPLC for TDM of MPA (1999) (3)
Stimulation of glucose metabolism in human blood cells by inhibitors of carnitine-dependent fatty acid transport. (1990) (2)
Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression. (2000) (2)
[Determination of theophylline in serum using radioactive-free immunoassays and high pressure liquid chromatography]. (1982) (2)
Hplc reference method for theophylline calibration by use of standard addition (1992) (2)
Evaluation of a Novel Bayesian Method for Individualizing Theophylline Dosage (1988) (2)
Quantitative liver function testing as a preoperative parameter in hepatic resection. (1994) (2)
Determination of theophylline in serum by non-isotopic immunoassays (EMIT, SLFIA, NIIA) and HPLC — A comparative study (1982) (2)
Therapeutic drug monitoring. (1984) (2)
Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients. (2001) (2)
Implementation of Medical Tests in a Value-Based Healthcare Environment A framework for delivering value. (2021) (2)
PROGNOSTIC INDICATORS IN LIVER CIRRHOSIS (1990) (2)
INFLUENCE OF TACROLIMUS ON MYCOPHENOLATE MOFETIL METABOLISM IN AN EX VIVO ISOLATED SMALL BOWEL PERFUSION MODEL (1999) (2)
Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liver perfusion model. (2001) (2)
Phenytoin measured by kinetic interaction of microparticles in solution (KIMS) homogeneous immunoassay: Multisite evaluation of the Roche OnLine (R) TDM method (2004) (2)
Predictive value of maternal bodyweight, postnatal weight gain and prenatal dexamethasone overexposure for the development of obesity in adult marmoset monkeys (2007) (2)
[Multiple organ failure after severe trauma: predictable by the MEGX liver function test?]. (1996) (2)
58 INTERACTION OF TACROLIMUS (FK 506) AND FLUCONAZOLE (1995) (2)
28 NONCOMPARTMENTAL PHARMACOKINETIC ANALYSIS OF MYCOPHENOLIC ACID CONCENTRATIONS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS (1997) (2)
SIMULTANEOUS DETERMINATION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE IN HUMAN PLASMA USING A SIMPLE HIGH-CHROMATOGRAPHY PROCEDURE (1998) (2)
Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis. (1999) (2)
MPA-AUC models in relation to outcome in pediatric KTx (1999) (2)
Individualizing theophylline dosage: Evaluation of a single-point maintenance dose prediction method (2004) (2)
Ciclosporin: HPLC routine method with column switching (1986) (2)
Die Untersuchung zellfreier DNA durch Liquid Biopsy in der Medizin (2019) (2)
CYP2D6 und Tamoxifen: pharmakogenetische Neuentdeckung eines etablierten Medikaments? / CYP2D6 and tamoxifen: pharmacogenetic reinvention of an established drug? (2009) (2)
REPLACING STEROIDS AFTER LIVER TRANSPLANTATION (1999) (2)
EXTRAHEPATIC GLUCURONIDATION OF MYCOPHENOLIC ACID IN HUMAN GUT AND KIDNEY (1999) (2)
International Association of Therapeutic Drug Monitoring and Clinical Toxicology Newsletter (2002) (2)
Cell-free DNA for treatment monitoring and outcome predictor in head and neck cancer. (2017) (2)
Chapter 7 – Graft-derived cell-free DNA as a marker of graft integrity after transplantation (2016) (2)
Determination of Triiodothyronine in Serum by Enzyme- and Radioimmunoassay. A Comparative Study (1981) (2)
MULTI-CENTER EVALUATION OF AN IMMUNOASSAY FOR THE MEASUREMENT OF SIROLIMUS ON THE ABBOTT IMX® ANALYZER. (2004) (2)
Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice (2014) (1)
[Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure]. (1983) (1)
Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantation (2015) (1)
Biomarkers of Disease: Biomarkers of hepatic disease (2002) (1)
Heat-shock protein 70 gene expression in a pig liver cold ischemia/reperfusion model: Influence of storage time and gadolinium chloride (1995) (1)
Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation (2022) (1)
A Prospective Evaluation of the Association Between Adverse Drug Reactions to Azathioprine Therapy and Polymorphisms in the Gene Encoding Inosine Triphosphate Pyrophosphatase: 133 (2005) (1)
Cost-minimization analysis of using tumor cell-free DNA as monitoring tool in cancer immunotherapy. (2019) (1)
HPLC methods for therapeutic drug monitoring involving direct serum injection, column switching, and simple mobile phase adjustments (1986) (1)
The Role of Therapeutic Drug Monitoring in Disease Management: Introduction (1998) (1)
Individualization of Theophylline Dosage: A Bayesian Method Evaluated in Patients with Once‐Daily Dosing (1991) (1)
Reflecting Potential Vaccine Candidates and Allergens (2006) (1)
20 CLINICAL EXPERIENCE OF MYCOPHENOLIC ACID (MPA) MONITORING FOLLOWING LIVER (LTX) AND KIDNEY TRANSPLANTATION (KTX) (1997) (1)
FK 506 and Cyclosporin Compared with Regard to Early Post-Transplant Liver Function (1993) (1)
Chip-based genotyping: translation of pharmacogenetic research to clinical practice. (2007) (1)
29 PENTAMER FORMATION ASSAY FOR DETERMINATION OF TACROLIMUS AND ITS ACTIVE METABOLITES IN WHOLE BLOOD (1997) (1)
Therapeutic drug monitoring and pharmacokinetic dose prediction methods. (1992) (1)
Lidocaine metabolite formation as a measure of liver function in hepatic transplantation (1990) (1)
mRNA amount and expression in a stable reporter gene assay system efficiency and modulates effects of the 20210G>A polymorphism on The intronic prothrombin 19911A>G polymorphism influences splicing (2010) (1)
QSA 10 (idebenone) or probucol supplementation of organ preservation solutions prevents oxygen radical-mediated injury of hepatic microsomes. (1995) (1)
012 Lipid hydroperoxide determination in serum by HPLC and iodometry (1992) (1)
Measurement of Erythrocyte ITPA Activity by HPLC and Correlation of ITPA Genotype- Phenotype in a Caucasian Population (2005) (1)
Lipid Interference in the Determination of the Concentration of Haemoglobin in Plasma Using the ACA SX Analyzer (1996) (1)
[Methods and clinical evaluation of a new enzyme immunologic method for determination of thyroxin binding globulin (TBG) and T4/TBG quotient: a multicenter study]. (1985) (1)
Quantification Of Serum Caspofungin By Liquid Chromatography Tandem Mass Spectrometry: 171 (2005) (1)
189 CYCLOSPORIN TROUGH LEVELS CORRELATE WITH SERUM LIPOPROTEINS AND APOLIPOPROTEINS IN RENAL TRANSPLANT RECIPIENTS (1995) (1)
MULTIPLES ORGANVERSAGEN NACH SCHWEREM TRAUMA : VORHERSAGBAR DURCH DEN LEBERFUNKTIONSTEST MEGX ? (1996) (1)
Foerfarande Foer framstaellning of saosom laekemedel anvaendbara N-substituted-2-hydrazono-propionsyraderivat (1978) (0)
Leberfunktionsdiagnostik bei polytraumatisierten Patienten mittels MEGX-Test (1992) (0)
Inhibition of gluconeogenesis by sodium nitroprusside in the perfused guinea pig liver. (1976) (0)
Zellfreie Tumor-DNA in der molekularen Diagnostik bei Kopf-Hals-Karzinomen (2021) (0)
Rapid Liquid Chromatography-Tandem Mass Spec- trometry Routine Method for Simultaneous Determina- tion of Sirolimus, Everolimus, Tacrolimus, and Cyclo- (2002) (0)
Single nucleotide polymorphisms of cy p3a5, but not of other genes, influence the exposure to tacrolimus in paediatric renal transplant recipients: a pharmacogenetic substudy of the twist study (2009) (0)
Proceedings of the Analytica Conference 2000 Symposium on Laboratory Evaluation and Monitoring of Transplant Recipients (2001) (0)
[In vitro evaluation of adsorbents used in haemoperfusion (author's transl)]. (1978) (0)
219 DETERMINATION OF MONOETHYLGLYCINEXYLIDIDE (MEGX) BY FPIA IN SERUM SAMPLES WITH HIGH BILIRUBIN: MODIFIED PRECIPITATION PROCEDURE AND HPLC COMPARED (1997) (0)
181 DOES HIGH-FLOW ASCITES COMPROMISE THE MEGX-TEST? (1995) (0)
Flucytosine: determination in serum by HPLC and dosage individualization. (1990) (0)
MYCOPHENOLATE MOFETIL TREATMENT CAUSES DOWN REGULATION OF GENES LINKED TO ALLOGRAFT ARTERIOSCLEROSIS AS REVEALED BY DNA MICROARRAY ANALYSIS (2004) (0)
Chapter 3.9. Single-Point Method and Bayesian Approach for Individualizing Theophylline Dosage (1989) (0)
[Pharmacokinetics of theophylline, proxyphylline and diprophylline in a combination preparation in healthy probands]. (1985) (0)
Assessment of Liver Function in Donors by Use of the MEGX Test (1992) (0)
185 AZATHIOPRINE PHARMACOGENETICS: THE RELATIONSHIP OF 6-THIOGUANINE NUCLEOTIDES AND TPMT IN HEART AND KIDNEY TRANSPLANT RECIPIENTS E (1995) (0)
EFFECT OF ISCHEMIA/REPERFUSION ON MYCOPHENOLIC ACID METABOLISM IN A PIG LIVER MODEL (1999) (0)
Analogifremgangsmaade for preparing 2-hydrazonopropionsyrederivater (1978) (0)
CLINICAL AND ECONOMIC BENEFIT BY OPTIMIZED AMINOGLYCOSIDE THERAPY IN NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN. (1999) (0)
Multicenter evaluation of the new Roche Carbamazepine OnLine (R) TDM assay developed for use on Roche Diagnostics/Hitachi analyzer systems (2004) (0)
MEGX FORMATION, LIVER BLOOD FLOW AND mRNA EXPRESSION OF CYP 3A4 IN CHRONIC END STAGE PEDIATRIC LIVER DISEASE (1998) (0)
High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation (2021) (0)
arrayed, and locations on the array are interrogated by successive hybridization with a set of molecules and exonuclease digestion steps that remove single-stranded oligonucleotides. Molecules remaining on the surface (2001) (0)
Effects of 2-(3-Methyl-cinnamyl-hydrazono)-propionate on Fatty Acid and Glucose Oxidation in the Isolated Rat Diaphragm Using 14C-Labelled Substrates. Hydrazonopropionic Acids, a New Class of Hypoglycaemic Substances, VIII (1988) (0)
2 Day Symposium to celebrate the career of Professor David W Holt (2010) (0)
Tobramycin profile. Report IX of the senate commission for clinical-toxicological analysis : VCH, Weinheim, 1988 (ISBN 0-89573-870-8). viii+30 pp (1989) (0)
EFFECT OF MYCOPHENOLIC ACID AND ITS METABOLITES ON TNF-α, IL-1β, AND IL-6 LIBERATION FROM HUMAN MONONUCLEAR LEUKOCYTES (1999) (0)
114 FALSE POSITIVE DIGOXIN LEVELS IN SERA FROM LIVER-TRANSPLANTED PATIENTS (1997) (0)
Donor Rating and Assessment of Pretransplant Prognosis by Use of the MEGX Test (1993) (0)
[Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations (author's transl)]. (1981) (0)
113 EVALUATION OF THE DIGOXIN ASSAY FOR THE IMMULITE® CHEMILUMINESCENT IMMUNOASSAY SYSTEM (1997) (0)
[The determination of total protein is not a suitable diagnosis for the treatment of hypoalbuminemia in intensive care patients]. (1995) (0)
32 PREDICTION OF MYCOPHENOLIC ACID PLASMA AUC BY A THREE POINT MODEL IN PEDIATRIC KIDNEY RECIPIENTS (1997) (0)
PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF FREE AND TOTAL MYCOPHENOLIC ACID IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: (1999) (0)
Performance characteristics of serum and salivary hormone quantification for luteal phase confirmation in behavioural studies (2008) (0)
Therapeutic drug monitoring and drugs of abuse testing on the cobas® 6000 analyzer series: analytical performance under routine-like conditions (2009) (0)
217 MEGX FORMATION AND EXPRESSION OF LIVER CYP3A4 mRNA COMPARED IN PEDIATRIC PATIENTS WITH CHRONIC END STAGE LIVER DISEASE (1997) (0)
Prognostic value of cell-free DNA in patients with oropharyngeal cancers. (2016) (0)
Evaluation of a Novel Bayesi&n Method for Individualizing Theophylline Dosage1) (1988) (0)
[Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations]. (1983) (0)
Multicenter evaluation of the new Roche Phenytoin ONLINE (R) TDM assay on RD/Hitachi systems (2003) (0)
CLINICAL EXPERIENCE WITH TACROLIMUS IN KIDNEY AND LIVER TRANSPLANT RECIPIENTS (1999) (0)
Special Collection on the Value of Laboratory Medicine. (2020) (0)
Analytic Aspects of Monitoring Therapy with Thiopurine Medications (2005) (0)
[Methods and clinical experiences with a thin-layer chromatography procedure for the detection of drugs in human urine (Drug-screen)]. (1974) (0)
Identification of drugs of abuse in urine by enzyme immunoassay (Emit) and thin-layer chromatography (Drug Skreen). A comparative study (1976) (0)
Substantial cost savings by individualized aminoglycoside therapy in febrile neutropenic patients with underlying malignant hematologic disorders (1999) (0)
THIOPURINE PHARMACOGENETICS: THE INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE (ITPASE) INTRONIC IVS2+21A>C MUTATION AFFECTS PURINE SYNTHESIS/SALVAGE PATHWAYS BY ACTING ON MRNA SPLICING EFFICIENCY (2004) (0)
[Therapy control by determination of serum drug concentrations]. (1982) (0)
Characterization of the Hepatic Excretory System by Serum Bilirubin Fractions and Total Bile Acids in the Early Course After Orthotopic Liver Transplantation (1991) (0)
INDUCTION OF INDUCIBLE NO-SYNTHASE IS AN ESSENTIAL PART OF TNFα-INDUCED APOPTOSIS IN MCF-7 CELLS (1996) (0)
Anti-allergic and anti-obstructive therapy by mast cell protection: theophylline. (1984) (0)
Determination of methotrexate in serum: the aca MTHO immunoassay and HPLC compared. (1990) (0)
NAT2 Genotypes and Their Relation to Schistosomiasis Associated Bladder Cancer in Egyptians: 26 (2005) (0)
[Determination of triiodothyronine in serum with a heterologous enzyme immunoassay: results of a group survey]. (1981) (0)
IN ALLER MUNDE : BARIGE VERPACKUNGSTRENDS BEI HARIBO (1999) (0)
[Determination of thyroxine in serum by a heterogeneous enzyme immunoassay: results of a joint trial]. (1979) (0)
Zirkulierende Transplantat-DNA als sensitiver Biomarker der Organintegrität nach Lebertransplantation (2014) (0)
45. FREE RADICAL SCA VENGING ENZYME ACTIVITIES IN ERYTHROCYTES AND PLASMA SELENIUM IN PAEDIATRIC CROHN'S DISEASE (1993) (0)
EVALUATION OF AN EMIT® TACROLIMUS ANTIBODY: COMPARISON WITH PENTAMER FORMATION ASSAY AND TACROLIMUS II MEIA (1999) (0)
Pharmacokinetic profiles of cyclosporin A in pediatric renal transplant recipients as predictor for the risk of acute rejection episodes (2004) (0)
Impact of pharmacogenetics on therapeutic drug monitoring (2009) (0)
85 Evaluation of a novel liver function test in pediatric liver disease (1988) (0)
Differential Expression of Proteins in Brain Regions of Alzheimer’s Disease Patients (2013) (0)
Prediction Accuracy Of Aminoglycosides Between Usc*pack And Pks: 188 (2005) (0)
[Cell-free tumor DNA in molecular diagnostics of head and neck cancer]. (2021) (0)
159First dose and steady state tacrolimus pharmacokinetics after liver transplantation (2000) (0)
MPA/MPAG LEVELS DURING IV MYCOPHENOLATE MOFETIL (CELLCEPT®) PROPHYLAXIS FOR ACUTE GVHD IN BMT/SCT RECIPIENTS. (1999) (0)
Intestinal biotransformation of cyclosporine A in an extracorporeal pig intestine perfusion model. (2001) (0)
PHARMACOKINETICS OF TACROLIMUS DURING THE EARLY PHASE AFTER LIVER TRANSPLANTATION (1999) (0)
WITHDRAWN: Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. (2006) (0)
UNTER DER HAUT : GROSSE TECHNIK EN MINIATURE : ELEKTRONISCHE KOMPONENTEN, STEUERUNGEN, SOFTWARE (1999) (0)
Hepatic ecNOS and CYP3A4 mRNA expression in chronic pediatric liver failure (1999) (0)
Results of the multicenter evaluation of the CEDIA cortisol assay. (1992) (0)
[Theophylline therapy in obstructive respiratory diseases. 2. Theophyllin-retard preparations for the long-term treatment of non-smokers with or without cardiac insufficiency (author's transl)]. (1981) (0)
Freie Radikalfängerenzyme und Spurenelemente bei Morbus Crohn (1995) (0)
[Changes in liver function and morphology after various portocaval bypass operations]. (1992) (0)
Prof. Dr. Victor William Armstrong 1948-2010 (2010) (0)
Prof. Dr. rer. nat. Victor William Armstrong (2010) (0)
[Dose titration with Euphylong following prior determination of serum concentration in the steady state]. (1990) (0)
COMPARISON OF THE ROCHE ELECSYS® DIGOXIN ASSAY WITH THE CHIRON ACS:180 PLUS (1999) (0)
Influence of 2(3-Methyl-cinnamyl-hydrazono)-propionate on Glucose and Palmitate Oxidation in Human Mononuclear Leukocytes. Hydrazonopropionic Acids, a New Class of Hypoglycaemic Substances, VII (1987) (0)
216 MONOETHYLGLYCINEXYLIDIDE (MEGX) FORMATION IN PATIENTS WITH LIVER CIRRHOSIS AND SCHISTOSOMAL HEPATIC FIBROSIS (1997) (0)
Applications et futur de la spectrométrie de masse en médecine de laboratoire (2015) (0)
PHARMOCOKINETICS OF MYCOPHENOLATE MOFETIL AND ENTERIC-COATED MYCOPHENOLATE SODIUM IN CALCINEURININHIBITOR-FREE TREATED RENAL TRANSPLANTAT PATIENTS: 183 (2010) (0)
[Practicability and reliability of opiate detection by immunoenzyme technics]. (1980) (0)
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study (2023) (0)
Cardiac troponin T A powerful marker to predict early cardiac death in patients with end-stage renal disease? (1999) (0)
PLASMA LEVELS OF MYCOPHENOLIC ACID AFTER ORAL MYCOFENOLAT MOFETIL IN PATIENTS AT HIGH RISK FOR GRAFT VERSUS HOST DISEASE (GVHD) AFTER BONE MARROW TRANSPLANTATION (1999) (0)
Biomarkers and Tolerance Induction in Transplantation HIKMA SESSION: Enhancing Long-Term Outcomes in Organ Transplantation Pediatric Heart Transplant, Congenital Heart Disease & Difficult Situations (2013) (0)
THERAPEUTIC WINDOW OF TACROLIMUS IN LIVER TRANSPLANTATION (1999) (0)
Erosive enterocolitis in MMF treated renal transplant recipients with persistent afebrile diarrhoea (2002) (0)
Monitoring Therapeutic Drugs in Clinical Chemical Laboratories (1982) (0)
[Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)]. (1979) (0)
Multicenter Evaluations Of The Roche Online® Tdm Assays For Use On Roche/hitachi Analyzer Systems: 90 (2005) (0)
N-substituted 2-hydrazono-propionic acid derivatives, processes for preparing the same and pharmaceutical compositions containing these (1977) (0)
185 PARTIAL SEQUENCE OF A PIG GENE WITH HIGH HOMOLOGY TO HUMAN CYP3A4 (1996) (0)
In Memoriam: Professor Folke Sjöqvist. (2020) (0)
Quantification by Liquid Chromatography Tandem Mass Spectrometry of Mycophenolic Acid and Its Phe- nol and Acyl Glucuronide Metabolites, Gunnar Brand- horst, (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael Oellerich?

Michael Oellerich is affiliated with the following schools:

Michael Oellerich's Academic­Influence.com Rankings

Michael Oellerich's Degrees

Why Is Michael Oellerich Influential?

Michael Oellerich's Published Works

Published Works

What Schools Are Affiliated With Michael Oellerich?

Michael Oellerich's AcademicInfluence.com Rankings